Cutler Group LP Unity Biotechnology, Inc. Transaction History

Cutler Group LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 18, 2022	SELL	$1.3 - $3.17 $390 - $951	-300 Closed	0 $0
Q1 2021 Apr 26, 2021	SELL	$5.51 - $9.42 $38,019 - $64,998	-6,900 Reduced 95.83%	300 $1,000
Q4 2020 Jan 21, 2021	BUY	$3.42 - $6.36 $18,126 - $33,708	5,300 Added 278.95%	7,200 $37,000
Q2 2020 Jul 22, 2020	BUY	$5.28 - $9.67 $1,056 - $1,934	200 Added 11.76%	1,900 $16,000
Q1 2020 May 07, 2020	BUY	$5.0 - $7.6 $6,500 - $9,880	1,300 Added 325.0%	1,700 $9,000
Q4 2019 Feb 06, 2020	BUY	$5.99 - $8.38 $2,396 - $3,352	400 New	400 $2,000

4.41M

Ticker UBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,036,200
Market Cap $14.5M
Description
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.